Linde (LIN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual General Meeting scheduled for July 29, 2025, at The Corinthia Hotel, London, with voting open until July 28, 2025, 11:59 PM ET.
Shareholders are encouraged to review proxy materials, including the 2024 Form 10-K, Annual Report, and Irish Financial Statements, before voting.
Voting matters and shareholder proposals
Election of ten directors, all recommended by the Board for approval.
Ratification of PricewaterhouseCoopers as independent auditor and authorization for the Audit Committee to determine their remuneration.
Advisory vote on executive compensation and recommendation on the frequency of future say-on-pay votes (Board recommends annual votes).
Approval sought for the price range at which treasury shares may be re-allotted under Irish law.
Shareholder proposal requesting an annual report on alignment of lobbying activities with 2050 climate neutrality ambition, with Board recommending a vote against.
Board of directors and corporate governance
Board recommends all director nominees for election, including Stephen F. Angel, Sanjiv Lamba, and others.
Latest events from Linde
- Record EPS, strong cash flow, and $10B backlog support 6–9% EPS growth outlook for 2026.LIN
Q4 20255 Feb 2026 - Adjusted EPS up 8%, margins at 29.3%, and $7.9B backlog, with strong capital returns.LIN
Q2 20242 Feb 2026 - Adjusted EPS up 9% and project backlog exceeds $10B, driving strong Q3 results.LIN
Q3 202417 Jan 2026 - Record EPS, 29.5% margin, $10.4B backlog, and 2025 EPS growth of 4–7% (8–11% ex FX).LIN
Q4 20248 Jan 2026 - Q1 2025: EPS up 5%, margins expand, strong cash flow and project backlog amid macro risks.LIN
Q1 202519 Dec 2025 - Shareholders will vote on directors, auditor, executive pay, and a climate lobbying report.LIN
Proxy Filing2 Dec 2025 - Q2 2025 saw higher sales, record margins, strong cash flow, and a robust project backlog.LIN
Q2 202513 Nov 2025 - Q3 sales up 3%, adjusted EPS up 7%, and full-year EPS guidance raised to 5–6% growth.LIN
Q3 202531 Oct 2025